Literature DB >> 21946278

Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap).

Yaser Fattahian1, Iraj Rasooli, Seyed Latif Mousavi Gargari, Mohammad Reza Rahbar, Shakiba Darvish Alipour Astaneh, Jafar Amani.   

Abstract

Acinetobacter baumannii, a major nosocomial pathogen, has remarkable capacity to acquire antimicrobial resistance attributable to its biofilm formation ability. Biofilm associated protein (Bap), a specific cell surface protein, is directly involved in biofilm formation by A. baumannii and plays a major role in bacterial infectious processes. In the present study we cloned, expressed and purified a 371 amino acid subunit of Bap. Mice were immunized using recombinant Bap subunit. They were then challenged with A. baumannii to evaluate the immunogenicity and protectivity of Bap subunit. Humoral immune response to Bap was determined by ELISA. Injection of Bap subunit resulted in high antibody titers. Decrease in bacterial cell counts of the immunized mice was evident 18 h after challenge. Reaction of antibodies against Bap with several strains suggests that not only immunodominant regions of Bap in A. baumannii strains are conserved but also have the same epitope presenting pattern in different strains. Immunodominant region of Bap possesses target sites for a protective humoral immune response to A. baumannii. This seems to be a conserved region erecting efficacy of Bap as an appropriate vaccine candidate.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946278     DOI: 10.1016/j.micpath.2011.09.004

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  35 in total

1.  Cloning of ompA gene from Acinetobacter baumannii into the eukaryotic expression vector pBudCE4.1 as DNA vaccine.

Authors:  Hossein Ansari; Abbas Doosti; Mohammad Kargar; Mahdi Bijanzadeh; Mojtaba Jaafarinia
Journal:  Indian J Microbiol       Date:  2018-02-09       Impact factor: 2.461

2.  Current advances and challenges in the development of Acinetobacter vaccines.

Authors:  Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.

Authors:  Ming-Hsien Chiang; Wang-Chou Sung; Shu-Pei Lien; Ying-Zih Chen; Annie Fei-yun Lo; Jui-Hsin Huang; Shu-Chen Kuo; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  A conserved region of Acinetobacter trimeric autotransporter adhesion, Ata, provokes suppression of Acinetobacter baumannii virulence.

Authors:  Ramin Hatefi Oskuei; Shakiba Darvish Alipour Astaneh; Iraj Rasooli
Journal:  Arch Microbiol       Date:  2021-04-27       Impact factor: 2.552

Review 5.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

6.  Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.

Authors:  Danilo G Moriel; Scott A Beatson; Daniël J Wurpel; Jeffrey Lipman; Graeme R Nimmo; David L Paterson; Mark A Schembri
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

7.  Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation.

Authors:  Jeremy A Iwashkiw; Andrea Seper; Brent S Weber; Nichollas E Scott; Evgeny Vinogradov; Chad Stratilo; Bela Reiz; Stuart J Cordwell; Randy Whittal; Stefan Schild; Mario F Feldman
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

8.  Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.

Authors:  Weiwei Huang; Yufeng Yao; Qiong Long; Xu Yang; Wenjia Sun; Cunbao Liu; Xiaomei Jin; Yang Li; Xiaojie Chu; Bin Chen; Yanbing Ma
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

9.  The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins.

Authors:  Daan de Gouw; Diego O Serra; Marien I de Jonge; Peter Wm Hermans; Hans Jct Wessels; Aldert Zomer; Osvaldo M Yantorno; Dimitri A Diavatopoulos; Frits R Mooi
Journal:  Emerg Microbes Infect       Date:  2014-08-20       Impact factor: 7.163

Review 10.  Inhibition of Virulence Factors and Biofilm Formation of Acinetobacter Baumannii by Naturally-derived and Synthetic Drugs.

Authors:  Nilushi Indika Bamunuarachchi; Fazlurrahman Khan; Young-Mog Kim
Journal:  Curr Drug Targets       Date:  2021       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.